Comparable stake leader
Michael Aronstein
SEC ownership of AngioGenex, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001085596.
Disclosed value leader
—
Comparable rows
0/4
Latest evidence
31 Dec 2021
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Michael Aronstein
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
31 Dec 2021
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001085596
- Issuer location
- New York, NY
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of AngioGenex, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Michael Aronstein
Disclosed value leader
—
Comparable rows
0/4
Latest evidence
31 Dec 2021
3/4/5
Some rows are evidence-backed but not safely comparable across classes.
4 rows are not safely comparable across share classes.
Quick read
SEC ownership evidence is available, but the rows are not safely comparable across share classes.
0 of 4 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Michael Aronstein's linked filing trail.
Detailed SEC evidence table Showing 1-4 of 4 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Michael Aronstein |
3/4/5
Director, CHAIRMAN, 10%+ Owner
|
—
mixed-class rows
|
—
17,747,827 shares
mixed-class rows
|
— | 31 Dec 2021 |
| Michael M. Strage |
3/4/5
Vice President, Director, 10%+ Owner
|
—
mixed-class rows
|
—
7,376,347 shares
mixed-class rows
|
— | 31 Dec 2021 |
| Robert Dickey IV |
3/4/5
Director, INDEPENDENT DIRECTOR
|
—
class O/S missing
|
—
850,000 shares
|
— | 31 Dec 2021 |
| Martin Murray |
3/4/5
Secretary, Treasurer, CFO, Director
|
—
class O/S missing
|
—
125,000 shares
|
— | 31 Dec 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 02 Jul 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-4 of 4 reporting-owner rows connected to AngioGenex, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
4
Largest Forms 3/4/5 holder
Michael M. Strage
Net 12M change
$0
Latest report
31 Dec 2021
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Michael M. Strage | Vice President, Director, 10%+ Owner | Mixed | 31 Dec 2021 | |||
| Michael Aronstein | Director, CHAIRMAN, 10%+ Owner | Mixed | 31 Dec 2021 | |||
| Robert Dickey IV | Director, INDEPENDENT DIRECTOR | Mixed | 31 Dec 2021 | |||
| Martin Murray | Secretary, Treasurer, CFO, Director | Mixed | 31 Dec 2021 |
Recent insider transactions for AngioGenex, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.